Diseases
Companies
Products
Productz
Mechanisms of Action
Sites
Esophageal Diseases
>>
Tyrosine Kinase Inhibitors
All trials
Active industry trials
Active owner-sponsored trials
Active trials
Export
Download options
Which format:
PDF
Excel Chart
TSV
Phase
N/A
1
2
3
4
Trials
0
2
4
6
8
10
12
14
16
18
20
Erbitux
(cetuximab) / Eli Lilly, EMD Serono
Avastin
(bevacizumab) / Roche
gefitinib
/ Generic mfg.
Vectibix
(panitumumab) / Amgen
erlotinib
/ Generic mfg.
lapatinib
/ Generic mfg.
sunitinib
/ Generic mfg.
Herceptin
(trastuzumab) / Roche
TheraCIM
(nimotuzumab) / Daiichi Sankyo, Oncoscience, Biocon
sorafenib
/ Generic mfg.
lucitanib
(E 3810) / Clovis, Servier
everolimus
/ Generic mfg.
matuzumab
(EMD 72000) / Takeda, EMD Serono
Caprelsa
(vandetanib) / Sanofi
Cyramza
(ramucirumab) / Eli Lilly
Gilotrif
(afatinib) / Boehringer Ingelheim
MM 111
/ Elevation Oncology
Vizimpro
(dacomitinib) / Pfizer
brivanib alaninate
(BMS-582664) / ZAI Lab
motesanib
(AMG 706) / Takeda
rilotumumab
(AMG 102) / Amgen
trebananib
(AMG 386) / Amgen
varlitinib
(ASLAN001) / ASLAN Pharma
